Pharmaceutical Care for Premature Infants with Candida Albicans Infection of the Central Nervous System

Abstract

Objective: To explore the role of clinical pharmacists in the treatment of clinical diseases by adjusting the treatment of Candida albicans infection in the central nervous system of a premature infant. Methods: Clinical pharmacists participated in the treatment of one premature infant with Candida albicans infection of the central nervous system, and provided drug selection suggestions based on drug safety and pharmacokinetics. Results: The doctor partially adopted the suggestions of clinical pharmacists, revised the medication plan, and the child received reasonable treatment. Conclusion: Clinical pharmacists can make full use of pharmaceutical knowledge to serve the clinic and improve the level of rational drug use.